By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) – Artificial intelligence has sped up early-stage drug development work at some of the world's largest
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 20 (Reuters) - Alphabet plans to raise C$6 billion ($4.19 billion) through a multi-tranche…
Nov 20 (Reuters) - Hunter Group ASA: * UPDATE ON RECOMMENDED CASH PURCHASE ORDER FOR…
VIDEO SHOWS: PRESS CONFERENCE COMMENTS FROM ARSENAL'S MANAGER MIKEL ARTETA AHEAD OF FACING NEWCASTLE UNITED…
Nov 20 (Reuters) - Ground Rents Income Fund PLC : * GROUND RENTS INCOME FUND:…
By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial…
By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial…